Regeneron Upgraded To Overweight From Neutral At Piper Jaffray
February 13, 2017 at 07:38 AM EST
Piper Jaffray analyst Edward Tenthoff upgraded Regeneron Pharmaceuticals to Overweight saying that while Eylea growth is slowing, new approvals are coming.
